Ronald Micetich : Dr. Ronald Micetich was appointed as Director
during March 2001. He is a south Indian born Canadian citizen
holds a doctorate in Organic Chemistry from the University
of Saskatchewan, Saskatoon, Canada. Commencing his career
as a research scientist at the R&L Molecular Research
Ltd. and Raylo Chemicals Ltd. Edmonton, he went on to become
the president and CEO at SynPharm Laboratories Inc, Edmonton.
His vast experience in areas of organic chemistry, pharmacology,
biotechnology, Chinese herbal medicines, nutraceuticals, bioassay
has helped him to be the man behind the discovery of two important
drugs, Tazobactum and Mofezolac or dispoain, a NSAID drug
popular in Japan for osteoarthritis and lumbago.